Discontinued — last reported Q1 '18
Allowance for Doubtful Accounts Receivable (Current)
Merck & Co. Allowance for Doubtful Accounts Receivable (Current) increased by 4.3% to $97.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.0%, from $89.00M to $97.00M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 2.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
Detailed definition
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Peer comparison
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $72.00M | $69.00M | $62.00M | $95.00M | $82.00M | $77.00M | $72.00M | $76.00M | $86.00M | $85.00M | $88.00M | $80.00M | $82.00M | $79.00M | $89.00M | $93.00M | $94.00M | $93.00M | $97.00M |
| QoQ Change | — | -4.2% | -10.1% | +53.2% | -13.7% | -6.1% | -6.5% | +5.6% | +13.2% | -1.2% | +3.5% | -9.1% | +2.5% | -3.7% | +12.7% | +4.5% | +1.1% | -1.1% | +4.3% |
| YoY Change | — | — | — | — | +13.9% | +11.6% | +16.1% | -20.0% | +4.9% | +10.4% | +22.2% | +5.3% | -4.7% | -7.1% | +1.1% | +16.3% | +14.6% | +17.7% | +9.0% |
Allowance for Doubtful Accounts Receivable (Current) at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s allowance for doubtful accounts receivable (current)?
- Merck & Co. (MRK) reported allowance for doubtful accounts receivable (current) of $97.00M in Q4 2025.
- How has Merck & Co.'s allowance for doubtful accounts receivable (current) changed year-over-year?
- Merck & Co.'s allowance for doubtful accounts receivable (current) increased by 9.0% year-over-year, from $89.00M to $97.00M.
- What is the long-term trend for Merck & Co.'s allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Merck & Co.'s allowance for doubtful accounts receivable (current) has grown at a 2.7% compound annual growth rate (CAGR), from $85.00M to $97.00M.
- What does allowance for doubtful accounts receivable (current) mean?
- The estimated portion of customer invoices that the company expects will never be paid.